These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 3266962

  • 1. Effect of levamisole on T cell in minimal change nephrotic syndrome.
    Dayal R, Prasad R, Mathur P, Sharma R, Elhence BR, Singh K.
    Indian Pediatr; 1988 Dec; 25(12):1184-7. PubMed ID: 3266962
    [No Abstract] [Full Text] [Related]

  • 2. [The study of T and B lymphocytes in glomerulopathy with minimal lesions].
    Sasdelli M, Cagnoli L, Rovinetti C, Beltrandi E, Catizone L, Zucchelli P.
    Minerva Nefrol; 1979 Dec; 26(2):145-9. PubMed ID: 314073
    [No Abstract] [Full Text] [Related]

  • 3. [Therapeutic trial with levamisole in children with idiopathic minimal change nephrotic syndrome].
    Urdaneta Carruyo E, Zúñiga Armendariz V, Gordillo Paniagua G.
    Bol Med Hosp Infant Mex; 1983 Feb; 40(2):82-8. PubMed ID: 6344884
    [No Abstract] [Full Text] [Related]

  • 4. Lymphocyte populations in chronic active liver disease: in vitro effect of levamisole on T-lymphocyte populations.
    Pozsonyi T, Fehér J, Jakab L.
    Allergol Immunopathol (Madr); 1981 Feb; 9(1):37-44. PubMed ID: 6973266
    [Abstract] [Full Text] [Related]

  • 5. The effect of levamisole on E-rosette formation by trypsinized lymphocytes.
    Lomnitzer R, Rabson AR.
    Clin Exp Immunol; 1978 Sep; 33(3):499-502. PubMed ID: 310743
    [Abstract] [Full Text] [Related]

  • 6. Restoration of E-rosette formation by levamisole and its abrogation by autochthonous serum from cattle with squamous cell carcinoma of horn.
    Dhingra VK, Gupta RK, Sadana JR.
    Res Vet Sci; 1982 Sep; 33(2):142-5. PubMed ID: 6983096
    [Abstract] [Full Text] [Related]

  • 7. [Role of cell-mediated immunity in children with lipoid nephrosis].
    Wojnarowski M, Woźniewicz B, Trzebiński A, Stawowska B, Wolff-Płodowska A.
    Pediatr Pol; 1981 Jul; 56(7):799-802. PubMed ID: 6975461
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Study of peripheral blood T-lymphocytes by the spontaneous and active "rosette" method using levamisole].
    Liapon AO, Lebedev KA, Mashkilleĭson AL.
    Biull Eksp Biol Med; 1980 May; 89(5):630-2. PubMed ID: 6967335
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Some T-cell functions in patients with viral myocarditis. The effect of levamisole.
    Goch JH, Czernicki J, Offierska M.
    Arch Immunol Ther Exp (Warsz); 1982 May; 30(5-6):395-404. PubMed ID: 6223612
    [Abstract] [Full Text] [Related]

  • 16. Effect of thymus factor and levamisole treatment in patients with persistent nephrotic syndrome.
    Czekalski S, Sulima D, Strzelecka G.
    Proc Eur Dial Transplant Assoc; 1983 May; 19():800-3. PubMed ID: 6603617
    [Abstract] [Full Text] [Related]

  • 17. Lymphocytes T and pharmacokinetics after a single oral dose of levamisole in healthy and cancer subjects.
    Luyckx M, Cazin M, Brunet C, Cazin JC, Devulder B, Gosselin P, Adenis L, Cappelaere P, Granier AM, Demaille A.
    Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):467-9. PubMed ID: 6608036
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunopathological alterations in minimal change nephrotic syndrome.
    Siddiqui JS, Kapoor AK, Rathi AK, Tuteja N, Kumar A, Mitra MK, Agrawal DK, Mehrotra RM.
    Indian J Med Res; 1982 Nov; 76():736-41. PubMed ID: 6984692
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.